BioSpace News Archive

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced financial results for the three and twelve months ended December 31, 2021 and highlighted recent corporate updates.

Inhibrx, Inc. reported financial results for the fourth quarter and fiscal year 2021 and provided an update on recent corporate highlights.

MiMedx Group, Inc., a transformational placental biologics company, announced the filing of its 2021 Annual Report on Form 10-K for the year ended December 31, 2021.

Jazz Pharmaceuticals plc announced that the Company will participate in the following upcoming virtual investor conferences.

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, 2021.

Sage Therapeutics, Inc. announced that the Company will participate in a fireside chat at the Cowen 42nd Annual Healthcare Conference on Monday, March 7, 2022 at 10:30am ET.

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today presented data for its lead oral drug candidate, KVD900, in development for on-demand treatment of hereditary angioedema (HAE), at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Scientific Meeting.

UroGen Pharma Ltd. announced that it will participate in a panel discussion at the upcoming virtual Cowen 42nd Annual Healthcare Conference on March 8, 2022 at 10:30am Eastern Time.

Element Biosciences Inc. today announced a partnership with Fabric Genomics Inc. to explore commercialization of end-to-end clinical application solutions based on Element’s AVITI system and the Fabric Enterprise clinical interpretation platform.

Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it will work with Inhibrx in an effort to develop a predictive biomarker for INBRX-109 in solid tumors.